Skip to content
Tenfell
Awarded contract
Published 03 Jul 2020

NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A

NHS England · London

Key facts

Awarded
02 Jun 2020
Contract starts
30 Jun 2020
Contract ends
30 Jun 2022
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Pfizer Ltd—
Novo Nordisk—
Roche Products Ltd—
Octapharma Limited—
Grifols Uk Ltd—
Bio Products Laboratory—
Biotest UK Ltd—
Swedish Orphan Biovitrum Ltd (Sobi Ltd),.,.,.,.,.,.,.,.,.,.,.,—
Shire Pharmaceuticals Limited—

Description

NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.7.2020 for a period of 24 months until 30.6.2022, with options to extend up to a maximum period of 24 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.